Authors
- Marija Brestovac — University of Zagreb School of Medicine, Zagreb, Croatia — ORCID: 0000-0003-1542-2890
- Blanka Glavaš Konja — University of Zagreb School of Medicine, Zagreb, Croatia — ORCID: 0000-0003-1134-4856
- Martina Lovrić Benčić — University of Zagreb School of Medicine, Zagreb, Croatia — ORCID: 0000-0001-8446-6120
- Vlatka Rešković Lukšić — University of Zagreb School of Medicine, Zagreb, Croatia — ORCID: 0000-0002-4721-3236
- Kristina Gašparović — University of Zagreb School of Medicine, Zagreb, Croatia — ORCID: 0000-0002-1191-4831
- Jadranka Šeparović Hanževački — University of Zagreb School of Medicine, Zagreb, Croatia — ORCID: 0000-0002-3437-6407
Abstract
**Introduction**: Cardiac resynchronization therapy (CRT) is a widely used method in the treatment of symptomatic patients with advanced heart failure and LBBB. Its beneficial impact on the reduction of left ventricular (LV) volumes has already been shown. (1, 2) The aim of this study was to determine if echocardiographic optimization of CRT pacing intervals (ECHO) after CRT device implantation has a favorable impact on LV volume change compared to electrocardiographic optimization (ECG). **Patients and Methods**: An overall of 147 patients with implanted CRT according to guidelines were included in this study and divided into two groups according to the CRT optimization method (N=70 in ECG arm an N=77 in ECHO arm). ECG optimization was performed using 12-lead electrocardiogram, fusion-optimized intervals, intracardiac electrogram-based algorithms and electrocardiographic imaging. ECHO optimization implied correction of atrioventricular, inter- and intraventricular dyssynchrony using echocardiographic imaging. The change in LV end-diastolic (EDV), end-systolic (ESV) and stroke volume (SV) as well as LV ejection fraction (EF) was compared between groups, before and 6 months after CRT implantation. **Results**: EDV and ESV significantly decreased and EF increased in both groups. In the ECHO a statistically significant reduction in EDV compared to ECG was present (p=0.028). According to greater EDV reduction, SV significantly decreased in ECHO (p=0.026). No significance was observed in ESV change between groups (p=0.063) (**Table 1**). ### TABLE 1: Left ventricle volumes and ejection fraction change before and 6 months after cardiac resynchronization therapy between the analyzed groups. | | **ECG (N=70)** | **ECG (N=70)** | **ECG (N=70)** | **ECHO (N=77)** | **ECHO (N=77)** | **ECHO (N=77)** | | | --- | --- | --- | --- | --- | --- | --- | --- | | | Before CRT | 6 months after CRT | Mean change, SD | Before CRT | 6 months after CRT | Δ | | | EDV (ml) | 218.81 | 167.48 | 51.32 (±64.25) | 231.81 | 157.53 | 74.28 (±80.25) | **p= 0.028** | | ESV (ml) | 162.27 | 112.25 | 50.01 (±59.38) | 169.67 | 102.57 | 67.1 (±75.02) | p= 0.063 | | SV (ml) | 56.54 | 55.23 | 1.31 (±16.46) | 62.14 | 54.96 | 7.18 (±19.66) | **p= 0.026** | | EF (%) | 26.67 | 36.79 | 10.11 (±8.39) | 26.97 | 39.13 | 12.16 (±10.80) | p= 0.1 | [†] EDV - left ventricular end-diastolic volume, ESV - left ventricular end-systolic volume, SV - left ventricular stroke volume, EF - left ventricular ejection fraction, SD - standard deviation. **Conclusion**: ECHO optimization of CRT leads to a more significant reduction of EDV compared to ECG optimization after 6 months of follow up.
Keywords
cardiac resynchronization therapy, echocardiographic optimization, left ventricular volume
DOI
https://doi.org/10.15836/ccar2021.203Literature
- St John Sutton MG, Plappert T, Abraham WT, Smith AL, DeLurgio DB, Leon AR, et al. Multicenter InSync Randomized Clinical Evaluation (MIRACLE) Study Group. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation. 2003 April 22;107(15):1985–90. https://doi.org/10.1161/01.CIR.0000065226.24159.E9
- St John Sutton M, Cerkvenik J, Borlaug BA, Daubert C, Gold MR, Ghio S, et al. Effects of Cardiac Resynchronization Therapy on Cardiac Remodeling and Contractile Function: Results From Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE). J Am Heart Assoc. 2015 September 11;4(9):e002054. https://doi.org/10.1161/JAHA.115.002054